Recent surgical management of gliomas

Advances in Experimental Medicine and Biology

Volumn 746, Issue , 2012, Pages 12-25

  Sanai, Nader ^a   Berger, Mitchel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIOLOGICAL PROCEDURE; ARTICLE; AWAKE CRANIOTOMY; BRAIN DEPTH STIMULATION; BRAIN MAPPING; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CORTICAL STIMULATION MAPPING; CRANIOTOMY; EVIDENCE BASED PRACTICE; EXTENT OF RESECTION; FUNCTIONAL NEUROIMAGING; GLIOMA; HUMAN; INTRAOPERATIVE LANGUAGE MAPPING; LANGUAGE DISABILITY; NEGATIVE LANGUAGE MAPPING; NEUROMONITORING; NEUROSURGERY; NONHUMAN; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TAILORED CRANIOTOMY; TREATMENT OUTCOME;

BRAIN MAPPING; BRAIN NEOPLASMS; CEREBRAL CORTEX; GLIOMA; HUMANS; LANGUAGE DISORDERS; MAGNETIC RESONANCE IMAGING; MONITORING, INTRAOPERATIVE; NEUROSURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84862999439     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3146-6_2     Document Type: Article

References (111)

1. Foerster O. The cerebral cortex of man. Lancet 1931; 2:309-312.
2. Penfield W, Bolchey E. Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 1937; 60:389-443.
3. Penfield W, Erickson TC. Epilepsy and cerebral localization. A study of the mechanism, treatment and prevention of epileptic seizures. Springfield: Charles C. Thomas, 1941.
4. Penfield W, Rasmussen T. Secondary sensory and motor representation. New York: Macmillan, 1950.
5. Ranck JB Jr. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res 1975; 98:417-440.
6. Haglund MM, Ojemann GA, Blasdel GG. Optical imaging of bipolar cortical stimulation. J Neurosurg 1993; 78:785-793. (Pubitemid 23121921)
7. Haglund MM, Ojemann GA, Hochman DW. Optical imaging of epileptiform and functional activity in human cerebral cortex. Nature 1992; 358:668-671.
8. Herholz K, Thiel A, Wienhard K et al. Individual functional anatomy of verb generation. Neuroimage 1996; 3:185-194. (Pubitemid 26199054)
9. Ojemann G, Ojemann J, Lettich E et al. Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg 1989; 71:316-326. (Pubitemid 19225542)
10. Ojemann GA, Whitaker HA. Language localization and variability. Brain Lang 1978; 6:239-260. (Pubitemid 9068413)
11. Ojemann GA. Individual variability in cortical localization of language. J Neurosurg 1979; 50:164-169. (Pubitemid 9114829)
12. Ojemann JG, Miller JW, Silbergeld DL. Preserved function in brain invaded by tumor. Neurosurgery 1996; 39:253-258; discussion 258-259.
13. Seitz RJ, Huang Y, Knorr U et al. Large-scale plasticity of the human motor cortex. Neuroreport 1995; 6:742-744.
14. Wunderlich G, Knorr U, Herzog H et al. Precentral glioma location determines the displacement of cortical hand representation. Neurosurgery 1998; 42:18-26; discussion 26-17.
15. Quinones-Hinojosa A, Ojemann SG, Sanai N et al. Preoperative correlation of intraoperative cortical mapping with magnetic resonance imaging landmarks to predict localization of the Broca area. J Neurosurg 2003; 99:311-318. (Pubitemid 36900127)
16. Seghier ML, Lazeyras F, Pegna AJ et al. Variability of fMRI activation during a phonological and semantic language task in healthy subjects. Hum Brain Mapp 2004; 23:140-155. (Pubitemid 39441686)
17. Tzourio-Mazoyer N, Josse G, Crivello F et al. Interindividual variability in the hemispheric organization for speech. Neuroimage 2004; 21:422-435. (Pubitemid 38115032)
18. Turkeltaub PE, Eden GF, Jones KM et al. Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002; 16:765-780. (Pubitemid 34852439)
19. Tzourio N, Crivello F, Mellet E et al. Functional anatomy of dominance for speech comprehension in left handers vs right handers. Neuroimage 1998; 8:1-16. (Pubitemid 28359563)
20. Dehaene S, Dupoux E, Mehler J et al. Anatomical variability in the cortical representation of first and second language. Neuroreport 1997; 8:3809-3815. (Pubitemid 28004880)
21. Steinmetz H, Seitz RJ. Functional anatomy of language processing: neuroimaging and the problem of individual variability. Neuropsychologia 1991; 29:1149-1161.
22. Josse G, Herve PY, Crivello F et al. Hemispheric specialization for language: Brain volume matters. Brain Res 2006; 1068:184-193. (Pubitemid 43139277)
23. Davies KG, Maxwell RE, Jennum P et al. Language function following subdural grid-directed temporal lobectomy. Acta Neurol Scand 1994; 90:201-206. (Pubitemid 24305923)
24. FitzGerald DB, Cosgrove GR, Ronner S et al. Location of language in the cortex: a comparison between functional MR imaging and electrocortical stimulation. Am J Neuroradiol 1997; 18:1529-1539. (Pubitemid 30413970)
25. Skirboll SS, Ojemann GA, Berger MS et al. Functional cortex and subcortical white matter located within gliomas. Neurosurgery 1996; 38:678-684; discussion 684-675.
26. Ojemann GA. Models of the brain organization for higher integrative functions derived with electrical stimulation techniques. Hum Neurobiol 1982; 1:243-249. (Pubitemid 13187657)
27. Ojemann GA. Cortical organization of language. J Neurosci 1991; 11:2281-2287.
28. Ojemann GA, Creutzfeldt OD. Nervous system V, Part 2. In: Plum F, ed. Handbook of Physiology. Bethesda: American Physiological Society Press, 1987:675-700.
29. Ojemann GA. Organization of language cortex derived from investigations during neurosurgery. Seminars in Neuroscience 1990; 2:297-305.
30. Haglund MM, Berger MS, Shamseldin M et al. Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 1994; 34:567-576; discussion 576. (Pubitemid 24100522)
31. Taylor MD, Bernstein M. Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 1999; 90:35-41. (Pubitemid 29024737)
32. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980; 30:907-911. (Pubitemid 10059239)
33. Wallner KE, Galicich JH, Krol G et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16:1405-1409. (Pubitemid 19154322)
34. Ebeling U, Steinmetz H, Huang YX et al. Topography and identification of the inferior precentral sulcus in MR imaging. Am J Roentgenol 1989; 153:1051-1056. (Pubitemid 19269379)
35. Herholz K, Reulen HJ, von Stockhausen HM et al. Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. Neurosurgery 1997; 41:1253-1260; discussion 1260-1252.
36. Carpentier A, Pugh KR, Westerveld M et al. Functional MRI of language processing: dependence on input modality and temporal lobe epilepsy. Epilepsia 2001; 42:1241-1254. (Pubitemid 33070663)
37. Sartorius CJ, Berger MS. Rapid termination of intraoperative stimulation-evoked seizures with application of cold Ringers lactate to the cortex. Technical note. J Neurosurg 1998; 88:349-351. (Pubitemid 28063615)
38. Duffau H, Capelle L, Denvil D et al. Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 2003; 98:764-778. (Pubitemid 36396778)
39. Duffau H, Capelle L, Sichez N et al. Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain 2002; 125:199-214. (Pubitemid 34084048)
40. Lacroix M, Abi-Said D, Fourney DR et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection and survival. J Neurosurg 2001; 95:190-198. (Pubitemid 32799739)
41. Sanai N, Berger MS. Mapping the horizon: techniques to optimize tumor resection before and during surgery. Clin Neurosurg 2008; 55:14-19.
42. Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. New Engl J Med 2008; 358:18-27.
43. Berger MS. Lesions in functional ("eloquent") cortex and sub-cortical white matter. Clin Neurosurg 1993; 41:443-463.
44. Chollet F, DiPiero V, Wise RJ et al. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991; 29:63-71.
45. Weder B, Seitz RJ. Deficient cerebral activation pattern in stroke recovery. Neuroreport 1994; 5:457-460. (Pubitemid 24128640)
46. Lewine JD, Astur RS, Davis LE et al. Cortical organization in adulthood is modified by neonatal infarct: a case study. Radiology 1994; 190:93-96.
47. Maldjian J, Atlas SW, Howard RS 2nd et al. Functional magnetic resonance imaging of regional brain activity in patients with intracerebral arteriovenous malformations before surgical or endovascular therapy. J Neurosurg 1996; 84:477-483. (Pubitemid 26062874)
48. Grady MS, Jane JA, Steward O. Synaptic reorganization within the human central nervous system following injury. J Neurosurg 1989; 71:534-537. (Pubitemid 19244269)
49. Fandino J, Kollias SS, Wieser HG et al. Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg 1999; 91:238-250.
50. Duffau H, Capelle L, Denvil D et al. Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry 2003; 74:901-907. (Pubitemid 36782992)
51. Thiel A, Herholz K, Koyuncu A et al. Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol 2001; 50:620-629. (Pubitemid 33021920)
52. Duffau H, Bauchet L, Lehericy S et al. Functional compensation of the left dominant insula for language. Neuroreport 2001; 12:2159-2163. (Pubitemid 32646264)
53. Black P. Management of malignant glioma: role of surgery in relation to multimodality therapy. J Neurovirol 1998; 4:227-236. (Pubitemid 28167497)
54. Yasargil MG, Kadri PA, Yasargil DC. Microsurgery for malignant gliomas. J Neurooncol 2004; 69:67-81. (Pubitemid 39256121)
55. Guthrie BL, Laws ER Jr. Supratentorial low-grade gliomas. Neurosurg Clin N Am 1990; 1:37-48.
56. Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999; 52:371-379. (Pubitemid 29505267)
57. Proescholdt MA, Macher C, Woertgen C et al. Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg 2005; 107:95-98. (Pubitemid 40228967)
58. Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neurooncol 1999; 42:303-305. (Pubitemid 29322205)
59. Grant R MS. Biopsy versus resection for malignant glioma (Review). The Cochrane Library, 2006.
60. Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990; 73:331-344. (Pubitemid 20260001)
61. Pierga JY, Hoang-Xuan K, Feuvret L et al. Treatment of malignant gliomas in the elderly. J Neurooncol 1999; 43:187-193. (Pubitemid 29445648)
62. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999; 42:227-231. (Pubitemid 29322199)
63. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008; 62:753-764; discussion 264-756.
64. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. New Engl J Med 2005; 352:997-1003. (Pubitemid 40349502)
65. Keles GE, Chang EF, Lamborn KR et al. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg 2006; 105:34-40. (Pubitemid 43979095)
66. Leighton C, Fisher B, Bauman G et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997; 15:1294-1301. (Pubitemid 27167360)
67. Nakamura M, Konishi N, Tsunoda S et al. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 2000; 58:108-116. (Pubitemid 30113861)
68. Philippon JH, Clemenceau SH, Fauchon FH et al. Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993; 32:554-559. (Pubitemid 23099519)
69. Rajan B, Pickuth D, Ashley S et al. The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys 1994; 28:405-413. (Pubitemid 24020525)
70. Shaw E, Arusell R, Scheithauer B et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002; 20:2267-2276. (Pubitemid 34441653)
71. Yeh SA, Ho JT, Lui CC et al. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol 2005; 78:230-235.
72. Shaw EG, Daumas-Duport C, Scheithauer BW et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70:853-861. (Pubitemid 19150501)
73. Laws ER Jr, Taylor WF, Clifton MB et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984; 61:665-673. (Pubitemid 14009855)
74. North CA, North RB, Epstein JA et al. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 1990; 66:6-14. (Pubitemid 20197076)
75. Ito S, Chandler KL, Prados MD et al. Proliferative potential and prognostic evaluation of low-grade astrocytomas. J Neurooncol 1994; 19:1-9. (Pubitemid 24258535)
76. Nicolato A, Gerosa MA, Fina P et al. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. Surg Neurol 1995; 44:208-221; discussion 221-203.
77. Whitton AC, Bloom HJ. Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. Int J Radiat Oncol Biol Phys 1990; 18:783-786. (Pubitemid 20154033)
78. Shibamoto Y, Kitakabu Y, Takahashi M et al. Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 1993; 72:190-195. (Pubitemid 23182071)
79. Karim AB, Maat B, Hatlevoll R et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36:549-556. (Pubitemid 26404297)
80. Scerrati M, Roselli R, Iacoangeli M et al. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 1996; 61:291-296. (Pubitemid 26293725)
81. Lote K, Egeland T, Hager B et al. Survival, prognostic factors and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 1997; 15:3129-3140. (Pubitemid 27377505)
82. Peraud A, Ansari H, Bise K et al. Clinical outcome of supratentorial astrocytoma WHO grade II. Acta Neurochirurgica 1998; 140:1213-1222. (Pubitemid 29020984)
83. van Veelen ML, Avezaat CJ, Kros JM et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64:581-587. (Pubitemid 28204142)
84. Bauman G, Pahapill P, Macdonald D et al. Low grade glioma: a measuring radiographic response to radiotherapy. Can J Neurol Sci 1999; 26:18-22. (Pubitemid 29088319)
85. Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 2003; 99:854-862.
86. Claus EB, Horlacher A, Hsu L et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005; 103:1227-1233. (Pubitemid 40328094)
87. Smith JS, Chang EF, Lamborn KR et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26:1338-1345.
88. Vecht CJ, Avezaat CJ, van Putten WL et al. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 1990; 53:466-471. (Pubitemid 20189579)
89. Shibamoto Y, Yamashita J, Takahashi M et al. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 1990; 18:9-17. (Pubitemid 20174440)
90. Curran WJ Jr, Scott CB, Horton J et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 1992; 12:219-227.
91. Simpson JR, Horton J, Scott C et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993; 26:239-244. (Pubitemid 23156970)
92. Dinapoli RP, Brown LD, Arusell RM et al. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 1993; 11:1316-1321. (Pubitemid 23199136)
93. Jeremic B, Grujicic D, Antunovic V et al. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol 1994; 21:177-185. (Pubitemid 24313780)
94. Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 1995; 75:2727-2731.
95. Barker FG 2nd, Prados MD, Chang SM et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996; 84:442-448. (Pubitemid 26062869)
96. Brown PD, Maurer MJ, Rummans TA et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005; 57:495-504; discussion 495-504.
97. Buckner JC, Schomberg PJ, McGinnis WL et al. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 2001; 92:420-433. (Pubitemid 32664450)
98. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004; 6:227-235. (Pubitemid 39136506)
99. Stark AM, Nabavi A, Mehdorn HM et al. Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg Neurol 2005; 63:162-169; discussion 169. (Pubitemid 40174904)
100. Ushio Y, Kochi M, Hamada J et al. Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir 2005; 45:454-460; discussion 460-451. (Pubitemid 41382969)
101. Duncan GG, Goodman GB, Ludgate CM et al. The treatment of adult supratentorial high grade astrocytomas. J Neurooncol 1992; 13:63-72.
102. Hollerhage HG, Zumkeller M, Becker M et al. Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochirurgica 1991; 113:31-37.
103. Huber A, Beran H, Becherer A et al. (Supratentorial glioma: analysis of clinical and temporal parameters in 163 cases). Neurochirurgia 1993; 36:189-193. (Pubitemid 23359730)
104. Kowalczuk A, Macdonald RL, Amidei C et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997; 41:1028-1036; discussion 1036-1028.
105. Levin VA, Yung WK, Bruner J et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 2002; 53:58-66. (Pubitemid 34465808)
106. Phillips TL, Levin VA, Ahn DK et al. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Int J Radiat Oncol Biol Phys 1991; 21:709-714.
107. Pope WB, Sayre J, Perlina A et al. MR imaging correlates of survival in patients with high-grade gliomas. AJNR 2005; 26:2466-2474.
108. Prados MD, Gutin PH, Phillips TL et al. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992; 23:3-8.
109. Puduvalli VK, Hashmi M, McAllister LD et al. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 2003; 65:259-266. (Pubitemid 37505834)
110. Sandberg-Wollheim M, Malmstrom P, Stromblad LG et al. A randomized study of chemotherapy with procarbazine, vincristine and lomustine with and without radiation therapy for astrocytoma grades 3 and/ or 4. Cancer 1991; 68:22-29.
111. Tortosa A, Vinolas N, Villa S et al. Prognostic implication of clinical, radiologic and pathologic features in patients with anaplastic gliomas. Cancer 2003; 97:1063-1071. (Pubitemid 36173159)